Parallax Volatility Advisers, L.P. Reata Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $1,480 - $4,472	48 New	48 $4,000
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $53,345 - $75,170	-566 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $43,920 - $61,889	466 Added 466.0%	566 $56,000
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $10,203 - $18,462	100 New	100 $12,000
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $26,001 - $45,408	-278 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $16,166 - $22,599	-128 Reduced 31.53%	278 $43,000
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $50,408 - $100,582	406 New	406 $59,000
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $186,350 - $544,582	-2,499 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $34,703 - $46,630	-487 Reduced 16.31%	2,499 $200,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $76,321 - $92,651	-982 Reduced 24.75%	2,986 $282,000
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $205,939 - $403,902	3,968 New	3,968 $339,000
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $34,440 - $51,987	-1,722 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $38,555 - $57,290	1,722	1,722 $49,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.